HLA B27 Molecular Detection
Desired Epic Build
* = editable field
Cerner Primary Mnemonic: | HLX HLA B27 Genotype Case |
PDM | 238466 |
Informatics - Workgroup | Molpath inhouse |
Synonyms * | Ankylosing Spondylitis HLA-B27 Antigen HLX HLA B27 Genotype Case HLA Antigen B27 |
Display Name * | HLA B27 Molecular Detection |
Specimen Sources (combined Order Entry and Specimen Navigator) * | |
Specimen Types (combined Order Entry and Specimen Navigator) * |
Blood
|
Body Fluids (types sent through AOEs) | |
Specimen Navigator Specimen Types | |
Specimen Navigator Specimen Sources | |
Specimen Navigator Short Name | |
Ordering info (EPIC SmartText) | Ankylosing spondylitis (AS) is a rheumatic inflammatory disease that belongs to the group of spondyloarthropathies. Human leukocyte antigen B27 (HLA-B27) is strongly associated with AS. There has been an increasing appreciation of HLA-B27 positivity in facilitating the diagnosis of an early stage of AS. About 90% of AS patients are HLA-B27 positive, compared to 5-10% of the general population. In addition, an increased prevalence of HLA-B27 has been reported in patients with Reiter's syndrome, anterior uveitis, psoriatic arthritis, and inflammatory bowel disease. As a result, tests of HLA-B27 are a valuable adjunct in the diagnosis of these diseases. Limitations: This test does not rule out the B*27:06 and 27:09 alleles, which are not associated with spondyloarthropathies. Certain rare alleles present in less than 1 percent of the population will not be detected. Other rare, or uncharacterized alleles may occur which may lead to false positive or false negative results. |
IP Orderable (inpatient) | Yes |
OP Orderable (outpatient) | Yes |
AOEs * | |
AP AOEs | |
Special History | No |
Build Comments | |
Filter * | genetics |
Cerner Site Restrict | |
Cerner Results |
Actual Epic Build 3/11/2025
PROCEDURE ID | 115145 | ||||||||||||||||||||||||
PDM | 238466 | ||||||||||||||||||||||||
ORDER DISPLAY NAME | HLA B27 Molecular Detection | ||||||||||||||||||||||||
PROCEDURE NAME | HLA B27 GENOTYPING | ||||||||||||||||||||||||
PROCEDURE MASTER NUMBER | LAB11402 | ||||||||||||||||||||||||
SHORT PROCEDURE NAME | HLA B27 GENOTYPING | ||||||||||||||||||||||||
CATEGORY CODE | 21.0 | ||||||||||||||||||||||||
CATEGORY CODE RECORD NAME | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||||||||||||||
SYNONYMS | ANKYLOSING SPONDYLITIS HLA-B27 ANTIGEN HLX HLA B27 GENOTYPE CASE HLA ANTIGEN B27 |
||||||||||||||||||||||||
CLINICALLY ACTIVE | Yes | ||||||||||||||||||||||||
ORDERABLE | Yes | ||||||||||||||||||||||||
PERFORMABLE | Yes | ||||||||||||||||||||||||
FILTER GENOMICS | Generic Genomics Procedure | ||||||||||||||||||||||||
REFERENCE LINK URL | https://labs.northwell.edu/epic/test/115145 | ||||||||||||||||||||||||
ORDERING INSTRUCTIONS | Ankylosing spondylitis (AS) is a rheumatic inflammatory disease that belongs to the group of spondyloarthropathies. Human leukocyte antigen B27 (HLA-B27) is strongly associated with AS. There has been an increasing appreciati on of HLA-B27 positivity in facilitating the diagnosis of an early stage of AS. About 90% of AS patients are HLA-B27 positive, compared to 5-10% of the general population. In addition, an increased prevalence of HLA-B27 has b een reported in patients with Reiter's syndrome, anterior uveitis, psoriatic arthritis, and inflammatory bowel disease. As a result, tests of HLA-B27 are a valuable adjunct in the diagnosis of these diseases. Limitations: This test does not rule out the B*27:06 and 27:09 alleles, which are not associated with spondyloarthropathies. Certain rare alleles present in less than 1 percent of the population will not be detected. Other ra re, or uncharacterized alleles may occur which may lead to false positive or false negative results. |
||||||||||||||||||||||||
DEFAULT SPECIMEN TYPE | Blood | ||||||||||||||||||||||||
SPECIMEN TYPE PICK LIST | Blood | ||||||||||||||||||||||||
SPECIMEN TYPE LIST | |||||||||||||||||||||||||
OP SPECIMEN TYPE LIST | |||||||||||||||||||||||||
SPECIMEN SOURCE PICK LIST | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||||||||||
SPECIMEN SOURCE DEFAULT - MALE | Blood, Venous | ||||||||||||||||||||||||
SPECIMEN SOURCE DEFAULT - FEMALE | Blood, Venous | ||||||||||||||||||||||||
SPECIMEN SOURCE LIST | |||||||||||||||||||||||||
OP SPECIMEN SOURCE LIST | |||||||||||||||||||||||||
IP LAB TEST COMPONENTS FOR REPORT | HLXB27 | ||||||||||||||||||||||||
OP LAB TEST COMPONENTS FOR REPORT | HLXB27 | ||||||||||||||||||||||||
ORDER QUESTIONS | ["3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||
ORDER QUESTIONS RECORD NAME | NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY |
||||||||||||||||||||||||
INPATIENT ORDER QUESTIONS | ["3048500000"] | ||||||||||||||||||||||||
INPATIENT ORDER QUESTIONS RECORD NAME | |||||||||||||||||||||||||
ORDER SPECIFIC QUESTION OVERRIDE | Yes | ||||||||||||||||||||||||
INPATIENT QUESTION OVERRIDE | |||||||||||||||||||||||||
LOCATION RESTRICT LIST IP | |||||||||||||||||||||||||
LOCATION RESTRICT LIST IP RECORD NAME | |||||||||||||||||||||||||
LOCATION RESTRICT LIST INCLUDE IP | |||||||||||||||||||||||||
LOCATION RESTRICT LIST OP | |||||||||||||||||||||||||
LOCATION RESTRICT LIST OP RECORD NAME | |||||||||||||||||||||||||
LOCATION RESTRICT LIST INCLUDES OP | |||||||||||||||||||||||||
EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||
EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||
EDP IP SPECIMEN SOURCE | |||||||||||||||||||||||||
EDP OP SPECIMEN SOURCE | |||||||||||||||||||||||||
EDP IP SPECIMEN TYPE | |||||||||||||||||||||||||
EDP OP SPECIMEN TYPE | |||||||||||||||||||||||||
DERIVED EDP IP BUTTONS S | |||||||||||||||||||||||||
DERIVED EDP IP BUTTONS T | |||||||||||||||||||||||||
DERIVED EDP OP BUTTONS S | |||||||||||||||||||||||||
DERIVED EDP OP BUTTONS T | |||||||||||||||||||||||||
IP ORDERABLE | 1 | ||||||||||||||||||||||||
OP ORDERABLE | 1 | ||||||||||||||||||||||||
STANDARD LAB COMPONENTS | |||||||||||||||||||||||||
STANDARD LAB COMPONENTS RECORD NAME | |||||||||||||||||||||||||
COMPONENT DATA REQUIREMENT | |||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||
EPIC IP AOEs
| |||||||||||||||||||||||||
EPIC Components (results - crosswalked through Cerner) |